Angioedema
Showing 1 - 25 of 1,091
Tranexamic Acid for Angiotensin-converting Enzyme
Completed
- Angioedema
-
Dallas, TexasMethodist Dallas Medical Center
Oct 17, 2023
Teenagers and Non-histaminergic Angioedema With Normal C1
Not yet recruiting
- Hereditary Angioedema (HAE)
- Angioedema
- No Intervention
- (no location specified)
Jan 5, 2023
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium
Recruiting
- Hereditary Angioedema
- +11 more
- PHA-022121 low dose
- +3 more
-
Birmingham, Alabama
- +7 more
Dec 5, 2022
Genetic Variants in Hereditary Angioedema
Not yet recruiting
- Hereditary Angioedema With C1 Esterase Inhibitor Deficiency
-
Barcelona, Spain
- +1 more
Apr 17, 2023
Status of Dental Care Practices in Hereditary Angioedema
Recruiting
- Angio Edema Hereditary
- dental procedure
-
Grenoble, Francechu grenoble alpes CREAK
Mar 17, 2023
Hereditary Angioedema (HAE) Trial (CSL312)
Not yet recruiting
- Hereditary Angioedema (HAE)
- CSL312
- (no location specified)
Apr 17, 2023
Hereditary Angioedema Trial in Adelaide (ADX-324, Placebo)
Recruiting
- Hereditary Angioedema
- ADX-324
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jan 10, 2023
Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor Trial in Saint Louis (High ACE Activity Fresh Frozen Plasma, Normal
Recruiting
- Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor
- High ACE Activity Fresh Frozen Plasma
- Normal Saline
-
Saint Louis, MissouriBarnes-Jewish Hospital
Oct 24, 2022
Hereditary Angioedema Trial (KVD900 600 mg)
Not yet recruiting
- Hereditary Angioedema
- KVD900 600 mg
- (no location specified)
Aug 17, 2022
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)
Recruiting
- Hereditary Angioedema
- +9 more
- PHA-022121
- Placebo
-
Birmingham, Alabama
- +21 more
Aug 11, 2022
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)
Active, not recruiting
- Hereditary Angioedema
- +9 more
- PHA-022121
- Placebo
-
Birmingham, Alabama
- +35 more
Aug 23, 2022
Hereditary Angioedema Trial (KVD900 600 mg)
Not yet recruiting
- Hereditary Angioedema
- KVD900 600 mg
- (no location specified)
Aug 19, 2022
Hereditary Angioedema Trial in Amsterdam, Auckland, Cambridge (Biological NTLA-2002, Normal Saline IV Administration)
Recruiting
- Hereditary Angioedema
- Biological NTLA-2002
- Normal Saline IV Administration
-
Amsterdam, Netherlands
- +2 more
Jul 18, 2022
Lanadelumab in Participants With Hereditary Angioedema
Recruiting
- Hereditary Angioedema (HAE)
-
Tokyo, T, JapanTakeda selected site
Jun 22, 2022
Hereditary Angioedema Who Currently Receive Icatibant at Home
Not yet recruiting
- Hereditary Angioedema (HAE)
- No Intervention
-
London, United KingdomSciensus
Aug 4, 2022
Lanadelumab in Teenagers and Hereditary Angioedema (HAE)
Not yet recruiting
- Hereditary Angioedema (HAE)
- No Intervention
-
London, England, United KingdomBarts Health NHS Trust
Jul 20, 2022
Bradykinin-mediated Angioedema Attacks UsingTracking Smartphone
Not yet recruiting
- Bradykinin-mediated Angioedema
- Questionnaire on a smartphone application
- (no location specified)
Mar 21, 2022
Hereditary Angioedema, HAE Trial in Japan (BCX7353 capsules, Placebo oral capsule)
Completed
- Hereditary Angioedema, HAE
- BCX7353 capsules
- Placebo oral capsule
-
Chiba, Japan
- +9 more
Jan 12, 2023
Biomarker for Hereditary AngioEdema Disease
Completed
- C1 Esterase Inhibitor Deficiency
- +7 more
-
Yerevan, Armenia
- +6 more
Mar 23, 2022
Associated With Diagnosis and Severity of Bradykinin Angioedema
Recruiting
- Angio Edema
- Biobanking
-
Lille, FranceHop Claude Huriez Chu Lille
Apr 4, 2022